Elmar Jäckel

724 total citations
20 papers, 483 citations indexed

About

Elmar Jäckel is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Elmar Jäckel has authored 20 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 9 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Elmar Jäckel's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Elmar Jäckel is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (5 papers). Elmar Jäckel collaborates with scholars based in Germany, United States and United Kingdom. Elmar Jäckel's co-authors include Michael P. Manns, Hans L. Tillmann, Heiner Wedemeyer, Markus Cornberg, Johannes Wiegand, Peter Boknı́k, Joachim Neumann, Thomas Eschenhagen, Lynn D. Condreay and C.–Thomas Bock and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The FASEB Journal.

In The Last Decade

Elmar Jäckel

19 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elmar Jäckel Germany 11 286 284 102 98 53 20 483
Katsuhiko Fukuda Japan 12 240 0.8× 217 0.8× 66 0.6× 49 0.5× 50 0.9× 23 428
R. Gómez Spain 10 63 0.2× 188 0.7× 67 0.7× 26 0.3× 26 0.5× 19 343
Anna Rodella Italy 13 279 1.0× 290 1.0× 60 0.6× 117 1.2× 93 1.8× 33 555
Klaus‐Dieter Palitzsch Germany 9 100 0.3× 126 0.4× 54 0.5× 71 0.7× 15 0.3× 18 353
J. Aguilar‐Reina Spain 9 581 2.0× 478 1.7× 26 0.3× 29 0.3× 13 0.2× 15 650
David Goldstein United States 8 253 0.9× 251 0.9× 52 0.5× 21 0.2× 11 0.2× 12 368
Jean‐Baptiste Trabut France 10 294 1.0× 339 1.2× 78 0.8× 8 0.1× 33 0.6× 25 460
Andrew Tran United States 11 195 0.7× 226 0.8× 28 0.3× 35 0.4× 37 0.7× 32 435
Jeysen Yogaratnam United States 10 172 0.6× 211 0.7× 37 0.4× 29 0.3× 39 0.7× 22 342
Luis Ariel Billordo Argentina 10 43 0.2× 157 0.6× 51 0.5× 22 0.2× 26 0.5× 10 367

Countries citing papers authored by Elmar Jäckel

Since Specialization
Citations

This map shows the geographic impact of Elmar Jäckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elmar Jäckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elmar Jäckel more than expected).

Fields of papers citing papers by Elmar Jäckel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elmar Jäckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elmar Jäckel. The network helps show where Elmar Jäckel may publish in the future.

Co-authorship network of co-authors of Elmar Jäckel

This figure shows the co-authorship network connecting the top 25 collaborators of Elmar Jäckel. A scholar is included among the top collaborators of Elmar Jäckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elmar Jäckel. Elmar Jäckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldschmidt, Imeke, Norman Junge, Elmar Jäckel, et al.. (2022). Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease—A Case Report. Children. 9(5). 669–669. 13 indexed citations
2.
Memaran, Nima, et al.. (2020). Prospective assessment of subclinical cardiovascular damage and associated factors in liver transplant recipients. Transplant International. 34(1). 127–138. 2 indexed citations
3.
Dirks, Meike, Henning Pflugrad, Anita B. Tryc, et al.. (2019). Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation. Transplant Immunology. 58. 101248–101248. 6 indexed citations
4.
Schmitz, Birte, Henning Pflugrad, Anita B. Tryc, et al.. (2019). Brain metabolic alterations in patients with long‐term calcineurin inhibitor therapy after liver transplantation. Alimentary Pharmacology & Therapeutics. 49(11). 1431–1441. 9 indexed citations
5.
Rhein, Mathias, Elmar Jäckel, Michael P. Manns, et al.. (2018). Leptin Expression and Gene Methylation Patterns in Alcohol-Dependent Patients with Ethyltoxic Cirrhosis—Normalization After Liver Transplantation and Implications for Future Research. Alcohol and Alcoholism. 53(5). 511–517. 7 indexed citations
6.
Pflugrad, Henning, Anita B. Tryc, Xiaoqi Ding, et al.. (2017). Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation. Liver Transplantation. 24(1). 56–66. 31 indexed citations
7.
Suhling, Hendrik, Jens Gottlieb, Christoph Bara, et al.. (2016). Chronische Abstoßung. Der Internist. 57(1). 25–37. 3 indexed citations
8.
Suhling, Hendrik, Jens Gottlieb, Christoph Bara, et al.. (2016). [Chronic rejection: Differences and similarities in various solid organ transplants].. Der Internist. 57(1). 25–37. 2 indexed citations
9.
Markova, Antoaneta A., et al.. (2016). Aseptic arthritis due to parvovirus B19 infection immediately after kidney and pancreas transplantation. SHILAP Revista de lepidopterología. 1(3-4). 15–17.
10.
Heidrich, Benjamin, Sven Pischke, Fabian Helfritz, et al.. (2013). Hepatitis C virus core antigen testing in liver and kidney transplant recipients. Journal of Viral Hepatitis. 21(11). 769–779. 22 indexed citations
11.
Pischke, Sven, Ilka Engelmann, Jérôme Schlué, et al.. (2012). High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis. Journal of Hepatology. 56(5). 1063–1069. 19 indexed citations
12.
Deterding, Katja, Johannes Wiegand, Andreas Hahn, et al.. (2009). The German Hep-Net Acute Hepatitis C Cohort: Impact of Viral and Host Factors on the Initial Presentation of Acute Hepatitis C Virus Infection. Zeitschrift für Gastroenterologie. 47(6). 531–540. 22 indexed citations
13.
Wiegand, Johannes, Elmar Jäckel, Markus Cornberg, et al.. (2004). Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology. 40(1). 98–107. 62 indexed citations
14.
Wedemeyer, Heiner, Elmar Jäckel, Johannes Wiegand, Markus Cornberg, & Michael P. Manns. (2004). Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C. Hepatology. 39(5). 1201–1203. 28 indexed citations
15.
El‐Armouche, Ali, Thomas Rau, Oliver Zolk, et al.. (2003). Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes. The FASEB Journal. 17(3). 1–23. 93 indexed citations
16.
Wiegand, Johannes, Hans L. Tillmann, Elmar Jäckel, et al.. (2003). Immunological, virological and clinical long-term follow-up after interferon therapy of acute hepatitis C infection. Journal of Hepatology. 38. 181–181. 3 indexed citations
17.
Tillmann, Hans L., Elmar Jäckel, & M.P. Manns. (2000). Liver transplantation in autoimmune liver disease--selection of patients.. PubMed. 46(30). 3053–9. 19 indexed citations
18.
19.
Linck, Bettina, Peter Boknı́k, Hideo A. Baba, et al.. (1998). Long-term Beta Adrenoceptor-Mediated Alteration in Contractility and Expression of Phospholamban and Sarcoplasmic Reticulum Ca++-ATPase in Mammalian Ventricle. Journal of Pharmacology and Experimental Therapeutics. 286(1). 531–538. 31 indexed citations
20.
Wedemeyer, Heiner, et al.. (1998). [Is combination therapy of chronic hepatitis C with interferon alpha and ribavirin in primary interferon nonresponders indicated?--An analysis of personal experiences and review of the literature].. PubMed. 36(9). 819–27. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiko Fukuda Breakdown of academic impact, for papers by R. Gómez Breakdown of academic impact, for papers by Anna Rodella Breakdown of academic impact, for papers by Klaus‐Dieter Palitzsch Breakdown of academic impact, for papers by J. Aguilar‐Reina Breakdown of academic impact, for papers by David Goldstein Breakdown of academic impact, for papers by Jean‐Baptiste Trabut Breakdown of academic impact, for papers by Andrew Tran Breakdown of academic impact, for papers by Jeysen Yogaratnam Breakdown of academic impact, for papers by Luis Ariel Billordo
Rankless by CCL
2026